These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

561 related items for PubMed ID: 25393520

  • 1. Intermittent antibiotic therapy for nodular bronchiectatic Mycobacterium avium complex lung disease.
    Jeong BH, Jeon K, Park HY, Kim SY, Lee KS, Huh HJ, Ki CS, Lee NY, Shin SJ, Daley CL, Koh WJ.
    Am J Respir Crit Care Med; 2015 Jan 01; 191(1):96-103. PubMed ID: 25393520
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of clarithromycin and ethambutol for Mycobacterium avium complex pulmonary disease. A preliminary study.
    Miwa S, Shirai M, Toyoshima M, Shirai T, Yasuda K, Yokomura K, Yamada T, Masuda M, Inui N, Chida K, Suda T, Hayakawa H.
    Ann Am Thorac Soc; 2014 Jan 01; 11(1):23-9. PubMed ID: 24298907
    [Abstract] [Full Text] [Related]

  • 3. Multicentre, open label, randomised controlled trial comparing intermittent versus daily treatment for non-cavitary nodular/bronchiectatic Mycobacterium avium complex lung disease with rifampicin, ethambutol and clarithromycin (iREC): study protocol.
    Nakagawa T, Hashimoto H, Yagi M, Kogure Y, Sekimizu M, Saito AM, Ogawa K, Inoue Y.
    BMJ Open Respir Res; 2019 Jan 01; 6(1):e000434. PubMed ID: 31258920
    [Abstract] [Full Text] [Related]

  • 4. Response to Switch from Intermittent Therapy to Daily Therapy for Refractory Nodular Bronchiectatic Mycobacterium avium Complex Lung Disease.
    Koh WJ, Jeong BH, Jeon K, Park HY, Kim SY, Huh HJ, Ki CS, Lee NY, Shin SJ, Daley CL.
    Antimicrob Agents Chemother; 2015 Aug 01; 59(8):4994-6. PubMed ID: 25987622
    [Abstract] [Full Text] [Related]

  • 5. Factors related to response to intermittent treatment of Mycobacterium avium complex lung disease.
    Lam PK, Griffith DE, Aksamit TR, Ruoss SJ, Garay SM, Daley CL, Catanzaro A.
    Am J Respir Crit Care Med; 2006 Jun 01; 173(11):1283-9. PubMed ID: 16514112
    [Abstract] [Full Text] [Related]

  • 6. Macrolide/Azalide therapy for nodular/bronchiectatic mycobacterium avium complex lung disease.
    Wallace RJ, Brown-Elliott BA, McNulty S, Philley JV, Killingley J, Wilson RW, York DS, Shepherd S, Griffith DE.
    Chest; 2014 Aug 01; 146(2):276-282. PubMed ID: 24457542
    [Abstract] [Full Text] [Related]

  • 7. Peak Plasma Concentration of Azithromycin and Treatment Responses in Mycobacterium avium Complex Lung Disease.
    Jeong BH, Jeon K, Park HY, Moon SM, Kim SY, Lee SY, Shin SJ, Daley CL, Koh WJ.
    Antimicrob Agents Chemother; 2016 Oct 01; 60(10):6076-83. PubMed ID: 27480854
    [Abstract] [Full Text] [Related]

  • 8. Therapeutic drug monitoring in the treatment of Mycobacterium avium complex lung disease.
    Koh WJ, Jeong BH, Jeon K, Lee SY, Shin SJ.
    Am J Respir Crit Care Med; 2012 Oct 15; 186(8):797-802. PubMed ID: 22878282
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Clinical and molecular analysis of macrolide resistance in Mycobacterium avium complex lung disease.
    Griffith DE, Brown-Elliott BA, Langsjoen B, Zhang Y, Pan X, Girard W, Nelson K, Caccitolo J, Alvarez J, Shepherd S, Wilson R, Graviss EA, Wallace RJ.
    Am J Respir Crit Care Med; 2006 Oct 15; 174(8):928-34. PubMed ID: 16858014
    [Abstract] [Full Text] [Related]

  • 11. Intermittent Treatment with Azithromycin and Ethambutol for Noncavitary Mycobacterium avium Complex Pulmonary Disease.
    Moon SM, Yoo IY, Huh HJ, Lee NY, Jhun BW.
    Antimicrob Agents Chemother; 2019 Dec 20; 64(1):. PubMed ID: 31611366
    [Abstract] [Full Text] [Related]

  • 12. Effect of clarithromycin regimen for Mycobacterium avium complex pulmonary disease.
    Tanaka E, Kimoto T, Tsuyuguchi K, Watanabe I, Matsumoto H, Niimi A, Suzuki K, Murayama T, Amitani R, Kuze F.
    Am J Respir Crit Care Med; 1999 Sep 20; 160(3):866-72. PubMed ID: 10471610
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Macrolide resistant Mycobacterium avium complex pulmonary disease following clarithromycin and ethambutol combination therapy.
    Ito Y, Miwa S, Shirai M, Kanai M, Fujita K, Ohba H, Iwaizumi E, Oshima T, Kojima S, Suda T, Hayakawa H.
    Respir Med; 2020 Aug 20; 169():106025. PubMed ID: 32442113
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Early results (at 6 months) with intermittent clarithromycin-including regimens for lung disease due to Mycobacterium avium complex.
    Griffith DE, Brown BA, Cegielski P, Murphy DT, Wallace RJ.
    Clin Infect Dis; 2000 Feb 20; 30(2):288-92. PubMed ID: 10671330
    [Abstract] [Full Text] [Related]

  • 18. Long-term Follow-up of Mycobacterium avium Complex Lung Disease in Patients Treated With Regimens Including Clofazimine and/or Rifampin.
    Jarand J, Davis JP, Cowie RL, Field SK, Fisher DA.
    Chest; 2016 May 20; 149(5):1285-93. PubMed ID: 26513209
    [Abstract] [Full Text] [Related]

  • 19. Effective treatment for clarithromycin-resistant Mycobacterium avium complex lung disease.
    Adachi Y, Tsuyuguchi K, Kobayashi T, Kurahara Y, Yoshida S, Kagawa T, Hayashi S, Suzuki K.
    J Infect Chemother; 2020 Jul 20; 26(7):676-680. PubMed ID: 32171660
    [Abstract] [Full Text] [Related]

  • 20. Nodular bronchiectatic Mycobacterium avium complex pulmonary disease. Natural course on serial computed tomographic scans.
    Lee G, Lee KS, Moon JW, Koh WJ, Jeong BH, Jeong YJ, Kim HJ, Woo S.
    Ann Am Thorac Soc; 2013 Aug 20; 10(4):299-306. PubMed ID: 23952847
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.